Iovance Biotherapeutics (NASDAQ:IOVA): Q2 GAAP EPS of -$0.38 misses by $0.09.
Cash, equivalents, and short-term investments of $404.15M
Thursday, August 1, 2019
Corcept Therapeutics EPS beats by $0.07, beats on revenue
Corcept Therapeutics (NASDAQ:CORT): Q2 Non-GAAP EPS of $0.25 beats by $0.07; GAAP EPS of $0.17 misses by $0.01.
Revenue of $72.26M (+16.0% Y/Y) beats by $1.39M.
Shares +0.18%.
Medifast EPS beats by $0.07, beats on revenue
Medifast (NYSE:MED): Q2 GAAP EPS of $1.75 beats by $0.07.
Revenue of $187.1M (+59.5% Y/Y) beats by $5.36M.
Intersect ENT, Inc. EPS misses by $0.03, misses on revenue
Intersect ENT, Inc. (NASDAQ:XENT): Q2 GAAP EPS of -$0.36 misses by $0.03.
Revenue of $26.66M (+1.4% Y/Y) misses by $0.47M.
Shares -0.84%.
Bio-Rad Labs EPS beats by $0.23, beats on revenue
Bio-Rad Labs (NYSE:BIO): Q2 Non-GAAP EPS of $1.57 beats by $0.23.
Revenue of $572.6M (-0.6% Y/Y) beats by $7.72M.
Twist Bioscience EPS misses by $0.11, beats on revenue
Twist Bioscience (NASDAQ:TWST): Q3 GAAP EPS of -$0.92 misses by $0.11.
Revenue of $13.6M (+108.0% Y/Y) beats by $0.85M.
Select Medical EPS in-line, misses on revenue
Select Medical (NYSE:SEM): Q2 GAAP EPS of $0.33 in-line.
Revenue of $1.36M (-99.9% Y/Y) misses by $1.34B.
Subscribe to:
Posts (Atom)